Abstract Apathy is a highly prevalent and disabling neuropsychiatric syndrome, but its multi-dimensional structure is a challenge for progress towards better identification and treatment. A crucial unresolved question is whether social disengagement reflects a distinct deficit in social motivation or a by-product of diminished initiative or emotional blunting.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Sofia Toniolo
Working memory filtering at encoding and maintenance in healthy ageing, Alzheimer’s and Parkinson’s disease - Scientific Reports
Abstract The differential impact on working memory (WM) performance of distractors presented at encoding or during maintenance was investigated in Alzheimer’s Disease (AD), Parkinson’s Disease (PD) patients, elderly (EHC) and young healthy controls (YHC), (n = 28 per group). Participants reported the orientation of an arrow from a set of either two or three items, with a distractor present either at encoding or at maintenance. MRI data with hippocampal volumes was also acquired.
Apathy and effort‐based decision‐making in Alzheimer's disease and subjective cognitive impairment
1 INTRODUCTION Apathy (ie, diminished goal-directed behavior) is a prominent feature in several neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), and small vessel disease (SVD).1 It burdens patients and caregivers and is a marker of disease progression in some disorders.2, 3 In AD, up to 80% of patients develop apathy, even at early stages, making it a valuable preclinical marker.4 However, it remains poorly understood in AD, with limited behavioral...
Detection of cognitive deficits years prior to clinical diagnosis across neurological conditions
The authors have declared no competing interest. This work was funded by the Wellcome Trust (Wellcome Trust PhD clinical fellowship to XYT and Wellcome Trust Principal Research Fellowship to MH [206330/Z/17/Z]) and MRC (Clinician Scientist Fellowship to S.M. [MR/P00878/X]) and by the Oxford NIHR Biomedical Research Centre. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Performance and validation of a digital memory test across the Alzheimer's Disease continuum
The authors have declared no competing interest. This research was supported by funding from the Wellcome Trust (206330/Z/17/Z) and NIHR Oxford Health Biomedical Research Centre. YAT was supported by a PhD scholarship by the Friedrich-Ebert-Stiftung. The funder played no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript.
Safety, tolerability and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's Disease (ILiAD) trial
The authors have declared no competing interest. NCT03489044 All data produced in the present study are available upon reasonable request to the authors I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Effects of COVID-19 on cognition and brain health
Highlights Even months after recovery from COVID-19 infection, some people continue to experience neurological, psychiatric, and cognitive effects. Recent extensive research using electronic health records, cognitive testing, and neuroimaging has started to clarify the nature of some of these symptoms. COVID-19 offers an unprecedented opportunity to follow individuals from acute infection through to the emergence of post-viral illness on a broad scale.
Blood-Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework
Abstract : The definition of Alzheimer’s disease (AD) now considers the presence of the markers of amyloid (A), tau deposition (T), and neurodegeneration (N) essential for diagnosis. AD patients have been reported to have increased blood–brain barrier (BBB) dysfunction, but that has not been tested within the ATN framework so far. As the field is moving towards the use of blood-based biomarkers, the relationship between BBB disruption and AD-specific biomarkers requires considerable attention.
Greater cognitive reserve is related to lower cortical excitability in healthy cognitive aging, but not in early clinical Alzheimer’s disease
1. Introduction Cognitive reserve (CR) is a construct proposed to explain why the severity of brain pathology in many neurological disorders does not always predict cognitive impairment (Stern, 2009). CR is accumulated over a lifetime through a variety of educational, occupational, physical, social, and leisure experiences.
Structural atrophy and functional dysconnectivity patterns in the cerebellum relate to cerebral networks in svMCI
Alaka Acharya1, Peng Ren1, Liye Yi2, Weiming Tian1 and Xia Liang1,3* 1School of Life Science, Harbin Institute of Technology, Harbin, China 2Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China 3Laboratory for Space Environment and Physical Sciences, Harbin Institute of Technology, Harbin, China Subcortical vascular mild cognitive impairment (svMCI) is associated with structural and functional changes in the cerebral cortex affecting major...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sofia
Contact Sofia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack